ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+4.18%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$313M
AUM Growth
+$313M
Cap. Flow
+$32M
Cap. Flow %
10.22%
Top 10 Hldgs %
96.69%
Holding
15
New
2
Increased
1
Reduced
1
Closed
–

Top Buys

1
HRMY icon
Harmony Biosciences
HRMY
$28.6M
2
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
$9.25M
3
VRNA
Verona Pharma
VRNA
$5.55M

Top Sells

1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$11.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$150M 47.82%
3,989,412
– –
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$56.8M 18.14%
1,123,630
– –
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$28.6M 9.13%
+842,815
New +$28.6M
SNDX icon
4
Syndax Pharmaceuticals
SNDX
$1.41B
$15.1M 4.83%
1,025,000
– –
TECX
5
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$13.1M 4.2%
1,009,779
– –
SYRE icon
6
Spyre Therapeutics
SYRE
$996M
$12M 3.83%
1,691,151
– –
PSTX
7
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$9.25M 2.96%
+1,043,267
New +$9.25M
VRNA
8
Verona Pharma
VRNA
$9.16B
$8.32M 2.66%
1,332,485
+888,889
+200% +$5.55M
BCEL
9
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$5.42M 1.73%
387,653
– –
ZSAN
10
DELISTED
Zosano Pharma Corporation
ZSAN
$4.4M 1.41%
2,718,226
– –
OBSV
11
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.44M 1.1%
1,386,338
– –
MRKR icon
12
Marker Therapeutics
MRKR
$12M
$3M 0.96%
2,000,000
– –
ACRS icon
13
Aclaris Therapeutics
ACRS
$209M
$1.63M 0.52%
634,455
– –
VIRX
14
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.26M 0.4%
1,010,000
-9,090,000
-90% -$11.4M
NBRV
15
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.02M 0.33%
1,910,287
– –